Synapse - Ellen Basu

Results (101)

High-dose naxitamab plus stepped-up dosing of GM-CSF for high-risk neuroblastoma (HR-NB): Efficacy against histologically-evident primary refractory metastases in bone marrow (BM)

Meeting Abstract

Kushner, B. H.; Modak, S.; Basu, E. M.; Roberts, S. S.; Cheung, N. K. V.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Local anesthesia with general anesthesia for pediatric bone marrow procedures

Journal Article

Zarnegar-Lumley, S.; Lange, K. R.; Mathias, M. D.; Nakajima-Hatano, M.; Offer, K. M.; Ogu, U. O.; Ortiz, M. V.; Tan, K. S.; Kellick, M.; Modak, S.; more...
Pediatrics (2019)

Fulltext@MSK | Save

Reduced-dose radiation therapy to the primary site is effective for high-risk neuroblastoma: Results from a prospective trial

Journal Article

Casey, D. L.; Kushner, B. H.; Cheung, N. K. V.; Modak, S.; Basu, E. M.; Roberts, S. S.; LaQuaglia, M. P.; Wolden, S. L.
International Journal of Radiation Oncology, Biology, Physics (2019)

Fulltext@MSK | Save

Phase 1 study of entrectinib (RXDX-101), a TRK, ROS1, and ALK inhibitor, in children, adolescents, and young adults with recurrent or refractory solid tumors

Meeting Abstract

Desai, A. V.; Brodeur, G. M.; Foster, J.; Berg, S. L.; Basu, E. M.; Shusterman, S.; Sabnis, A. J.; Macy, M.; Yoon, J.; Gauvain, K.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Entrectinib in two pediatric patients with inflammatory myofibroblastic tumors harboring ROS1 or ALK gene fusions

Journal Article

Ambati, S. R.; Slotkin, E. K.; Chow-Maneval, E.; Basu, E. M.
JCO Precision Oncology (2018)

Fulltext@MSK | Save

Humanized 3F8 anti-G(D2) monoclonal antibody dosing with granulocyte-macrophage colony-stimulating factor in patients with resistant neuroblastoma: A phase 1 clinical trial

Journal Article

Kushner, B. H.; Cheung, I. Y.; Modak, S.; Basu, E. M.; Roberts, S. S.; Cheung, N. K.
JAMA Oncology (2018)

Fulltext@MSK | Save

Intraventricular 131I-labeled monoclonal antibody 8H9 (omburtomab) targeting the surface glycoprotein B7-H3 in patients with CNS malignancies

Meeting Abstract

Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Tomlinson, U.; Donzelli, M.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
Pediatric Blood and Cancer (2018)

Fulltext@MSK | Save

Feasibility of outpatient stem cell rescue in high risk neuroblastoma patients

Meeting Abstract

Glincher, R.; Modak, S.; Basu, E.
Pediatric Blood and Cancer (2018)

Fulltext@MSK | Save

Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study